Best Penny Stocks Under 50 Cents Right Now It can be difficult to find a deal in the stock market regardless of current market conditions. For the last decade, stocks have traded well above historical average P/E ratios. Fortunately there are still a handful of undervalued stocks in corners of the market that most investors ignore. These penny stocks all have a super-low share price of $0.50 or less and are sorted by average trading volume in dollars. These companies are considered the most actively-traded stocks priced under $0.50. OverviewStocks Under $0.05Stocks Under $0.10Stocks Under $0.25Stocks Under $0.50Stocks Under $1Stocks Under $2Stocks Under $3Stocks Under $5Stocks Under $10Stocks Under $20Stocks Under $30Stocks Under $50Stocks On Sale 1. Tilray Brands NASDAQ:TLRY$0.40 -0.01 (-2.84%) Closing price 04:00 PM EasternExtended Trading$0.40 +0.00 (+0.32%) As of 08:00 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Tilray, Inc engages in the research, cultivation, processing, and distribution of medical cannabis. The company offers its products in Argentina, Australia, Canada, Chile, Croatia, Cyprus, the Czech Republic, Germany, New Zealand, and South Africa. More about Tilray BrandsMarket Capitalization$415.08 millionP/E Ratio-0.38Consensus RatingHoldConsensus Price Target$1.92 (+378.3% Upside)Volume12.80 million sharesAverage Volume29.65 million shares Get the Latest News and Ratings for Your StocksEnter your email address below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter. 2. Wolfspeed NYSE:WOLF$0.40 -0.09 (-17.81%) Closing price 03:59 PM EasternExtended Trading$0.41 +0.01 (+2.50%) As of 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Wolfspeed, Inc operates as a powerhouse semiconductor company focuses on silicon carbide and gallium nitride (GaN) technologies in Europe, Hong Kong, China, rest of Asia-Pacific, the United States, and internationally. More about WolfspeedMarket Capitalization$75.74 millionP/E Ratio-0.05Consensus RatingHoldConsensus Price Target$11.15 (+2,688.5% Upside)Volume80.29 million sharesAverage Volume19.51 million shares3. EON Resources NYSEAMERICAN:EONR$0.34 -0.04 (-10.94%) As of 04:10 PM EasternEON Resources Inc, an independent oil and natural gas company, focuses on the acquisition, development, exploration, and production of oil and natural gas properties in the Permian Basin. More about EON ResourcesMarket Capitalization$7.66 millionConsensus RatingBuyConsensus Price Target$2.00 (+479.7% Upside)Volume2.90 million sharesAverage Volume15.14 million sharesToday's Range$0.34▼$0.394. Senseonics NYSE:SENS$0.49 -0.01 (-1.18%) Closing price 04:00 PM EasternExtended Trading$0.50 +0.00 (+0.59%) As of 07:33 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Senseonics Holdings, Inc, a medical technology company, focuses on development and manufacturing of continuous glucose monitoring (CGM) systems for people with diabetes in the United States and internationally. More about SenseonicsMarket Capitalization$323.25 millionP/E Ratio-3.80Consensus RatingStrong BuyConsensus Price Target$1.55 (+213.7% Upside)Volume6.92 million sharesAverage Volume7.03 million shares5. NuCana NASDAQ:NCNA$0.09 +0.00 (+4.00%) Closing price 04:00 PM EasternExtended Trading$0.07 -0.01 (-14.44%) As of 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.NuCana plc, a clinical-stage biopharmaceutical company, engages in the development of medicines to treat patients with cancer. More about NuCanaMarket Capitalization$500 thousandP/E Ratio-0.01Consensus RatingModerate BuyConsensus Price Target$25.00 (+29,003.6% Upside)Volume48.50 million sharesAverage Volume36.29 million shares6. Plus Therapeutics NASDAQ:PSTV$0.32 -0.05 (-14.05%) Closing price 04:00 PM EasternExtended Trading$0.31 -0.01 (-2.89%) As of 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Plus Therapeutics, Inc, a clinical-stage pharmaceutical company, focuses on the development, manufacture, and commercialization of treatments for patients with cancer. More about Plus TherapeuticsMarket Capitalization$18.70 millionP/E Ratio-0.11Consensus RatingModerate BuyConsensus Price Target$10.83 (+3,338.1% Upside)Volume23.76 million sharesAverage Volume9.85 million shares7. WW International NASDAQ:WW$0.25 -0.03 (-10.51%) As of 05/15/2025WW International, Inc provides weight management products and services worldwide. It offers a range of nutritional, activity, behavioral, and lifestyle tools and approaches products and services. More about WW InternationalMarket Capitalization$20.04 millionP/E Ratio-0.04Consensus RatingHoldConsensus Price Target$2.25 (+801.4% Upside)Volume10.45 million sharesAverage Volume11.45 million shares8. Leslie's NASDAQ:LESL$0.45 -0.04 (-8.72%) Closing price 04:00 PM EasternExtended Trading$0.46 +0.01 (+2.00%) As of 07:50 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Leslie's, Inc operates as a direct-to-consumer pool and spa care brand in the United States. The company markets and sells pool and spa supplies and related products and services. More about Leslie'sMarket Capitalization$91.41 millionP/E Ratio-1.88Consensus RatingReduceConsensus Price Target$2.27 (+404.4% Upside)Volume27.50 million sharesAverage Volume5.32 million shares9. Nikola NASDAQ:NKLA$0.18 -0.07 (-28.74%) Closing price 02/25/2025Extended Trading$0.18 0.00 (0.00%) As of 02/25/2025 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Nikola Corporation operates as a technology innovator and integrator that develops energy and transportation solutions in the United States and internationally. More about NikolaMarket Capitalization$11.14 millionP/E Ratio-0.01Consensus RatingHoldConsensus Price Target$6.00 (+3,178.7% Upside)Volume36.66 million sharesAverage Volume10.17 million shares10. Sunnova Energy International NYSE:NOVA$0.16 -0.06 (-28.25%) Closing price 06/9/2025Extended Trading$0.16 0.00 (0.00%) As of 06/9/2025 04:02 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Sunnova Energy International Inc engages in the provision of energy as a service in the United States. The company offers electricity, as well as offers operations and maintenance, monitoring, repairs and replacements, equipment upgrades, on-site power optimization, and solar energy system and energy storage system diagnostics services. More about Sunnova Energy InternationalMarket Capitalization$19.86 millionP/E Ratio-0.05Consensus RatingHoldConsensus Price Target$4.36 (+2,657.7% Upside)Volume4.22 million sharesAverage Volume11.21 million shares11. Carisma Therapeutics NASDAQ:CARM$0.40 -0.01 (-1.43%) Closing price 04:00 PM EasternExtended Trading$0.41 +0.01 (+2.35%) As of 07:52 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Carisma Therapeutics, Inc, a clinical-stage cell therapy company, focuses on discovering and developing immunotherapies to treat cancer and other serious diseases in the United States. More about Carisma TherapeuticsMarket Capitalization$16.98 millionP/E Ratio-0.26Consensus RatingHoldConsensus Price Target$1.93 (+380.5% Upside)Volume851,846 sharesAverage Volume3.84 million shares12. Harvard Bioscience NASDAQ:HBIO$0.46 -0.05 (-10.14%) Closing price 04:00 PM EasternExtended Trading$0.48 +0.02 (+3.26%) As of 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Harvard Bioscience, Inc develops, manufactures, and sells technologies, products, and services for life science applications in the United States and internationally. More about Harvard BioscienceMarket Capitalization$22.63 millionP/E Ratio-0.35Consensus RatingModerate BuyConsensus Price Target$3.00 (+552.2% Upside)Volume5.18 million sharesAverage Volume3.14 million shares13. Canoo NASDAQ:GOEV$0.34 -0.07 (-15.95%) Closing price 01/28/2025Extended Trading$0.34 0.00 (0.00%) As of 01/28/2025 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Canoo Inc, a mobility technology company, designs, develops, markets, and manufactures electric vehicles for consumer, commercial fleet, government, and military customers in the United States. More about CanooMarket Capitalization$1.67 millionP/E Ratio0.00Consensus RatingHoldConsensus Price Target$23.50 (+6,731.4% Upside)Volume6.24 million sharesAverage Volume3.68 million shares14. bioAffinity Technologies NASDAQ:BIAF$0.30 -0.06 (-17.75%) Closing price 04:00 PM EasternExtended Trading$0.29 -0.01 (-3.04%) As of 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.bioAffinity Technologies, Inc, a biotechnology company, engages in developing non-invasive diagnostic tests and targeted cancer therapeutics. More about bioAffinity TechnologiesMarket Capitalization$10.24 millionP/E Ratio-0.41Consensus RatingHoldConsensus Price Target$6.00 (+1,927.0% Upside)Volume7.97 million sharesAverage Volume4.10 million shares15. Vaxart NASDAQ:VXRT$0.49 -0.04 (-7.14%) Closing price 04:00 PM EasternExtended Trading$0.50 +0.00 (+0.71%) As of 07:56 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Vaxart, Inc, a clinical-stage biotechnology company, discovers and develops oral recombinant protein vaccines based on its proprietary oral vaccine platform. More about VaxartMarket Capitalization$121.57 millionP/E Ratio-1.83Consensus RatingBuyConsensus Price Target$3.00 (+506.7% Upside)Volume2.85 million sharesAverage Volume2.45 million shares16. Abpro NASDAQ:ABP$0.21 -0.01 (-5.38%) As of 04:00 PM EasternAbpro Holdings Inc is a biotechnology company. The company's mission is to improve the lives of mankind facing severe and life-threatening diseases with next-generation antibody therapies. More about AbproMarket Capitalization$13.56 millionConsensus RatingBuyConsensus Price Target$4.00 (+1,795.7% Upside)Volume2.64 million sharesAverage Volume5.52 million sharesToday's Range$0.21▼$0.2217. Brand Engagement Network NASDAQ:BNAI$0.38 +0.03 (+7.19%) Closing price 04:00 PM EasternExtended Trading$0.37 0.00 (-0.87%) As of 07:56 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Brand Engagement Network, Inc provides conversational AI assistants. The company offers security-focused, multimodal communication, and human-like assistants. More about Brand Engagement NetworkMarket Capitalization$15.13 millionP/E Ratio-0.44Consensus RatingBuyConsensus Price Target$6.00 (+1,490.2% Upside)Volume1.55 million sharesAverage Volume3.03 million shares18. Applied Therapeutics NASDAQ:APLT$0.32 -0.06 (-14.79%) Closing price 04:00 PM EasternExtended Trading$0.35 +0.02 (+6.86%) As of 07:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Applied Therapeutics, Inc, a clinical-stage biopharmaceutical company, engages in the development of a pipeline of novel product candidates against validated molecular targets in indications of high unmet medical need in the United States. More about Applied TherapeuticsMarket Capitalization$53.80 millionP/E Ratio-0.75Consensus RatingModerate BuyConsensus Price Target$6.10 (+1,783.9% Upside)Volume13.30 million sharesAverage Volume3.46 million shares19. Adial Pharmaceuticals NASDAQ:ADIL$0.34 -0.13 (-28.67%) Closing price 04:00 PM EasternExtended Trading$0.31 -0.02 (-7.19%) As of 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Adial Pharmaceuticals, Inc, a clinical-stage biopharmaceutical company, focuses on the development of therapeutics for the treatment or prevention of addiction and related disorders. More about Adial PharmaceuticalsMarket Capitalization$4.90 millionP/E Ratio-0.23Consensus RatingStrong BuyConsensus Price Target$8.00 (+2,287.3% Upside)Volume14.85 million sharesAverage Volume2.87 million shares20. Heatwurx NASDAQ:PCSA$0.20 -0.04 (-17.63%) Closing price 04:00 PM EasternExtended Trading$0.20 +0.00 (+2.45%) As of 07:58 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Processa Pharmaceuticals, Inc, a clinical stage biopharmaceutical company, develops chemotherapy drugs to improve the safety and efficacy of cancer treatment. More about HeatwurxMarket Capitalization$2.83 millionP/E Ratio-0.06Consensus RatingBuyConsensus Price Target$6.00 (+2,958.1% Upside)Volume8.88 million sharesAverage Volume4.84 million shares21. FiscalNote NYSE:NOTE$0.49 -0.04 (-7.88%) Closing price 03:59 PM EasternExtended Trading$0.51 +0.02 (+3.67%) As of 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.FiscalNote Holdings, Inc operates as technology company North America, Europe, Australia, and Asia. It combines artificial intelligence technology, machine learning, and other technologies with analytics, workflow tools, and expert research. More about FiscalNoteMarket Capitalization$84.15 millionP/E Ratio-1.48Consensus RatingBuyConsensus Price Target$2.63 (+437.4% Upside)Volume11.93 million sharesAverage Volume1.80 million shares22. Cognition Therapeutics NASDAQ:CGTX$0.30 -0.02 (-7.55%) Closing price 04:00 PM EasternExtended Trading$0.31 +0.01 (+4.00%) As of 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Cognition Therapeutics, Inc, a clinical-stage biopharmaceutical company, engages in the discovery and development of small molecule therapeutics targeting age-related degenerative diseases and disorders of the central nervous system and retina. More about Cognition TherapeuticsMarket Capitalization$20.12 millionP/E Ratio-0.41Consensus RatingBuyConsensus Price Target$5.63 (+1,775.0% Upside)Volume1.24 million sharesAverage Volume2.76 million shares23. Affimed NASDAQ:AFMD$0.18 -0.10 (-34.95%) As of 05/19/2025Affimed N.V., a clinical-stage biopharmaceutical company, focuses on discovering and developing cancer immunotherapies in the United States and Germany. More about AffimedMarket Capitalization$2.92 millionConsensus RatingHoldConsensus Price Target$3.62 (+1,895.9% Upside)Volume22.99 million sharesAverage Volume4.51 million sharesToday's Range$0.17▼$0.2424. Nuwellis NASDAQ:NUWE$0.24 -0.02 (-7.87%) Closing price 04:00 PM EasternExtended Trading$0.23 -0.01 (-4.50%) As of 07:58 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Nuwellis, Inc, a medical device company, develops, manufactures, and commercializes medical devices used in ultrafiltration therapy. More about NuwellisMarket Capitalization$1.13 millionP/E Ratio-0.01Consensus RatingBuyConsensus Price Target$17.00 (+7,051.9% Upside)Volume2.41 million sharesAverage Volume3.44 million shares25. Mersana Therapeutics NASDAQ:MRSN$0.29 -0.03 (-10.46%) Closing price 04:00 PM EasternExtended Trading$0.32 +0.03 (+11.00%) As of 07:50 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Mersana Therapeutics, Inc, a clinical stage biopharmaceutical company, develops antibody drug conjugates (ADC) for cancer patients with unmet needs. More about Mersana TherapeuticsMarket Capitalization$40.51 millionP/E Ratio-0.49Consensus RatingBuyConsensus Price Target$5.20 (+1,686.9% Upside)Volume15.79 million sharesAverage Volume2.69 million shares More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Nike Stock: The Mother of All Comebacks Might Have Just Begun EA Just Caught a Monster Upgrade: Bullish Breakout Ahead? Addition by Subtraction: Intel’s New Strategy Energizes Investors NVIDIA’s Stock Price Hits New Highs: This Is What’s Next Micron: A Hot Buy Heats Up, Fresh All-Time Highs Are Coming Rocket Lab: Europe Comes Calling as Momentum Builds Super Micro’s Bold $2B Bond Plan Signals 35% Premium Upside QuantumScape Soars 30%: What Drove the Next-Gen EV Stock's Rally Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
